Stephens reaffirmed their equal weight rating on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report released on Wednesday, Benzinga reports. They currently have a $4.00 price target on the stock. Several other research analysts have also commented on OCX. Benchmark reaffirmed a speculative buy rating and set a $5.00 price objective on […]
Investment analysts at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock. OncoCyte Stock Performance OCX stock opened at $2.98 on Friday. OncoCyte has a one year low of $2.08 and a one year high […]
OncoCyte (NASDAQ:OCX) Coverage Initiated by Analysts at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report issued on Thursday morning. The firm issued a sell rating on the stock. Several other research analysts also recently commented on OCX. Needham & Company LLC reduced their price objective on OncoCyte from $4.25 to $3.60 and set a buy rating […]
Stock analysts at StockNews.com initiated coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the stock. A number of other equities analysts have also commented on the stock. Needham & Company LLC decreased their price target on shares of […]